Announcement of the company’s cash capital increase and base date

Board of directors of the company waived subscription rights exceeding half of the total subscribable shares. Shares to be subscribed by designated persons
June 10, 2019
OBI-888 completes Phase I safety evaluation and demonstrates its safety and tolerability with no major concerns
June 15, 2019
  1. Date of occurrence of the event: Jun 14, 2019
  2. Company name: OBI Pharma Inc.
  3. Relationship to the Company (please enter “head office” or “subsidiaries”): head office
  4. Reciprocal shareholding ratios: N/A
  5. Cause of occurrence: Following “Criteria Governing the Offering and Issuance of Securities,” hereby announcing:
    (1)Number of shares issued are 15,000,000 shares at NTD 135 per share; NTD 2,025,000,000 paid-up
    (2)Record date of cash capital increase: Jun 14, 2019
    (3)Share effective date: Jun 19, 2019
  6. Countermeasures: none
  7. Any other matters that need to be specified: none